Redux dexfenfluramine: IPIC and partner Wyeth-Ayerst began a Phase IV trial

The two-year, double-blind trial will use behavioral and neuropsychological testing to

Read the full 114 word article

How to gain access

Continue reading with a
two-week free trial.